Respiratory patent battle continues with ResMed against BMC Medical
California respiratory devices maker ResMed petitions an International Trade Commission investigation against yet another foreign rival, this time targeting China's BMC Medical and its Florida distributors.
California medical device maker ResMed (NYSE:RMD) is taking another swing at Chinese respiratory technology rival BMC Medical, getting the International Trade Commission's cooperation in an investigation into potential patent infringement.
ResMed has challenged BMC before, suing the company and its Florida distributors, 3B Medical Inc. and 3B Product, for allegedly violating patents for respiratory and sleep-disordered breathing devices. ResMed hopes to land an ITC ruling that would prevent BMC's infringing products from entering the U.S.